WHO Updates List of Most Threatening Drug-Resistant Bacteria as Pharma Warns New Antibiotic Pipeline is Inadequate 17/05/2024 Kerry Cullinan The World Health Organization (WHO) has updated its list of antibiotic-resistant bacteria that pose the greatest threat to human health, ranking the 15 families of bacteria that feature as “critical”, “high” and “medium” threats. The Bacterial Priority Pathogens List (BPPL) 2024’s “critical” list features bacteria that are high burden, can resist treatment and spread resistance […] Continue reading -> Trial of Super-Vaccine Against Coronaviruses Expected in 2025 14/05/2024 Zuzanna Stawiska Researchers have developed a new all-in-one vaccine aimed at priming the body to respond to a range of different strains of coronaviruses, including the ones not yet known. The researchers from Cambridge, MIT and CalTech published their findings recently in Nature Nanotechnology. Their vaccine was successfully tested on mice and will likely enter human clinical trials […] Continue reading -> More African Countries Roll Out Malaria Vaccine, While Babies Get New Treatment Formulation 30/04/2024 Zuzanna Stawiska Rollout of malaria vaccines are starting in Benin, Sierra Leone and Liberia, and the West African countries plan to deliver more than 800 000 doses of the RTS,S or R21 vaccines, according to WHO. The new vaccine will be added to their immunisation programmes for children, and are expected to protect over 200,000 children from […] Continue reading -> Colombia Issues Compulsory License to Enable it to Access Generic HIV Drug, Dolutegravir 25/04/2024 Kerry Cullinan The government of Colombia has issued its first-ever compulsory license to enable access to generic versions of the key HIV medicine dolutegravir, without permission from the patent owner, ViiV Healthcare. Dolutegravir is recommended as part of the preferred first-line antiretroviral treatment regimen for people living with HIV, including during pregnancy, as per the guidance of […] Continue reading -> Immunisation Saved At Least 154 Million Lives Over Past 50 Years – WHO 24/04/2024 Kerry Cullinan Immunisation has saved at least 154 million lives over the past 50 years, since the World Health Organization (WHO) launched its Expanded Programme on Immunization (EPI) in 1974. Of the lives saved, 146 million were children under five, and 101 million were babies. Global infant deaths have reduced by 40% and more than halved in […] Continue reading -> Study Finds Adult Vaccination Programs Deliver 19x Returns 18/04/2024 Maayan Hoffman Amidst the anticipated increase in vaccine-preventable diseases as the global population ages, a first-of-its-kind study has underscored the dual benefits of adult immunization programs. Beyond saving lives and preventing severe illnesses, the study found these programs offer substantial financial advantages to nations by reducing the need for costly hospitalizations and emergency medical interventions and avoiding […] Continue reading -> Moderna’s ‘Disappointing’ Pull Back from Kenya Highlights Complexity of Expanding Vaccine Manufacturing in Africa 16/04/2024 Kerry Cullinan “Disappointed” is how the Africa Centres for Disease Control and Prevention phrased its response to pharmaceutical company Moderna “pausing” its Kenyan mRNA vaccine manufacturing facility. Moderna’s decision is yet another example of how complex it is to kickstart vaccine manufacturing on the continent – an essential component to safeguard Africans against future pandemics on the […] Continue reading -> Nigeria Becomes First Country in World to Roll out New Five-in-One Meningitis Vaccine 15/04/2024 Zuzanna Stawiska Nigeria has incorporated a cutting-edge meningitis vaccine into its immunization programmes, becoming the first country on the continent to roll it out. The vaccine provides immunity against as many as five strains of deadly meningococcus bacteria, WHO announced on Friday. “Meningitis is an old and deadly foe, but this new vaccine holds the potential to […] Continue reading -> New Dengue Vaccine Trials Show Promise in Brazil as Cases Continue to Rise 10/04/2024 Sophia Samantaroy As global cases of dengue are already close to last year’s record high of over four million, the Americas region is struggling to contain high transmission levels. Unplanned urbanization, heavier rainfall, warmer temperatures, and the El Nino effect create perfect conditions for the Aedes aegypti mosquito, the primary vector of dengue. The Southern Cone region […] Continue reading -> Amid Global Cholera Surge, Gavi Launches New Testing Programme 10/04/2024 Zuzanna Stawiska A new programme aiming at providing 1.2 million rapid cholera diagnostic tests has been launched in 14 African and Asian countries. “Routine use of diagnostics will bolster cholera surveillance in impacted countries, and must be leveraged to better target vaccination efforts, which play a critical role in multisectoral cholera prevention and control programmes,” said Aurélia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Trial of Super-Vaccine Against Coronaviruses Expected in 2025 14/05/2024 Zuzanna Stawiska Researchers have developed a new all-in-one vaccine aimed at priming the body to respond to a range of different strains of coronaviruses, including the ones not yet known. The researchers from Cambridge, MIT and CalTech published their findings recently in Nature Nanotechnology. Their vaccine was successfully tested on mice and will likely enter human clinical trials […] Continue reading -> More African Countries Roll Out Malaria Vaccine, While Babies Get New Treatment Formulation 30/04/2024 Zuzanna Stawiska Rollout of malaria vaccines are starting in Benin, Sierra Leone and Liberia, and the West African countries plan to deliver more than 800 000 doses of the RTS,S or R21 vaccines, according to WHO. The new vaccine will be added to their immunisation programmes for children, and are expected to protect over 200,000 children from […] Continue reading -> Colombia Issues Compulsory License to Enable it to Access Generic HIV Drug, Dolutegravir 25/04/2024 Kerry Cullinan The government of Colombia has issued its first-ever compulsory license to enable access to generic versions of the key HIV medicine dolutegravir, without permission from the patent owner, ViiV Healthcare. Dolutegravir is recommended as part of the preferred first-line antiretroviral treatment regimen for people living with HIV, including during pregnancy, as per the guidance of […] Continue reading -> Immunisation Saved At Least 154 Million Lives Over Past 50 Years – WHO 24/04/2024 Kerry Cullinan Immunisation has saved at least 154 million lives over the past 50 years, since the World Health Organization (WHO) launched its Expanded Programme on Immunization (EPI) in 1974. Of the lives saved, 146 million were children under five, and 101 million were babies. Global infant deaths have reduced by 40% and more than halved in […] Continue reading -> Study Finds Adult Vaccination Programs Deliver 19x Returns 18/04/2024 Maayan Hoffman Amidst the anticipated increase in vaccine-preventable diseases as the global population ages, a first-of-its-kind study has underscored the dual benefits of adult immunization programs. Beyond saving lives and preventing severe illnesses, the study found these programs offer substantial financial advantages to nations by reducing the need for costly hospitalizations and emergency medical interventions and avoiding […] Continue reading -> Moderna’s ‘Disappointing’ Pull Back from Kenya Highlights Complexity of Expanding Vaccine Manufacturing in Africa 16/04/2024 Kerry Cullinan “Disappointed” is how the Africa Centres for Disease Control and Prevention phrased its response to pharmaceutical company Moderna “pausing” its Kenyan mRNA vaccine manufacturing facility. Moderna’s decision is yet another example of how complex it is to kickstart vaccine manufacturing on the continent – an essential component to safeguard Africans against future pandemics on the […] Continue reading -> Nigeria Becomes First Country in World to Roll out New Five-in-One Meningitis Vaccine 15/04/2024 Zuzanna Stawiska Nigeria has incorporated a cutting-edge meningitis vaccine into its immunization programmes, becoming the first country on the continent to roll it out. The vaccine provides immunity against as many as five strains of deadly meningococcus bacteria, WHO announced on Friday. “Meningitis is an old and deadly foe, but this new vaccine holds the potential to […] Continue reading -> New Dengue Vaccine Trials Show Promise in Brazil as Cases Continue to Rise 10/04/2024 Sophia Samantaroy As global cases of dengue are already close to last year’s record high of over four million, the Americas region is struggling to contain high transmission levels. Unplanned urbanization, heavier rainfall, warmer temperatures, and the El Nino effect create perfect conditions for the Aedes aegypti mosquito, the primary vector of dengue. The Southern Cone region […] Continue reading -> Amid Global Cholera Surge, Gavi Launches New Testing Programme 10/04/2024 Zuzanna Stawiska A new programme aiming at providing 1.2 million rapid cholera diagnostic tests has been launched in 14 African and Asian countries. “Routine use of diagnostics will bolster cholera surveillance in impacted countries, and must be leveraged to better target vaccination efforts, which play a critical role in multisectoral cholera prevention and control programmes,” said Aurélia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
More African Countries Roll Out Malaria Vaccine, While Babies Get New Treatment Formulation 30/04/2024 Zuzanna Stawiska Rollout of malaria vaccines are starting in Benin, Sierra Leone and Liberia, and the West African countries plan to deliver more than 800 000 doses of the RTS,S or R21 vaccines, according to WHO. The new vaccine will be added to their immunisation programmes for children, and are expected to protect over 200,000 children from […] Continue reading -> Colombia Issues Compulsory License to Enable it to Access Generic HIV Drug, Dolutegravir 25/04/2024 Kerry Cullinan The government of Colombia has issued its first-ever compulsory license to enable access to generic versions of the key HIV medicine dolutegravir, without permission from the patent owner, ViiV Healthcare. Dolutegravir is recommended as part of the preferred first-line antiretroviral treatment regimen for people living with HIV, including during pregnancy, as per the guidance of […] Continue reading -> Immunisation Saved At Least 154 Million Lives Over Past 50 Years – WHO 24/04/2024 Kerry Cullinan Immunisation has saved at least 154 million lives over the past 50 years, since the World Health Organization (WHO) launched its Expanded Programme on Immunization (EPI) in 1974. Of the lives saved, 146 million were children under five, and 101 million were babies. Global infant deaths have reduced by 40% and more than halved in […] Continue reading -> Study Finds Adult Vaccination Programs Deliver 19x Returns 18/04/2024 Maayan Hoffman Amidst the anticipated increase in vaccine-preventable diseases as the global population ages, a first-of-its-kind study has underscored the dual benefits of adult immunization programs. Beyond saving lives and preventing severe illnesses, the study found these programs offer substantial financial advantages to nations by reducing the need for costly hospitalizations and emergency medical interventions and avoiding […] Continue reading -> Moderna’s ‘Disappointing’ Pull Back from Kenya Highlights Complexity of Expanding Vaccine Manufacturing in Africa 16/04/2024 Kerry Cullinan “Disappointed” is how the Africa Centres for Disease Control and Prevention phrased its response to pharmaceutical company Moderna “pausing” its Kenyan mRNA vaccine manufacturing facility. Moderna’s decision is yet another example of how complex it is to kickstart vaccine manufacturing on the continent – an essential component to safeguard Africans against future pandemics on the […] Continue reading -> Nigeria Becomes First Country in World to Roll out New Five-in-One Meningitis Vaccine 15/04/2024 Zuzanna Stawiska Nigeria has incorporated a cutting-edge meningitis vaccine into its immunization programmes, becoming the first country on the continent to roll it out. The vaccine provides immunity against as many as five strains of deadly meningococcus bacteria, WHO announced on Friday. “Meningitis is an old and deadly foe, but this new vaccine holds the potential to […] Continue reading -> New Dengue Vaccine Trials Show Promise in Brazil as Cases Continue to Rise 10/04/2024 Sophia Samantaroy As global cases of dengue are already close to last year’s record high of over four million, the Americas region is struggling to contain high transmission levels. Unplanned urbanization, heavier rainfall, warmer temperatures, and the El Nino effect create perfect conditions for the Aedes aegypti mosquito, the primary vector of dengue. The Southern Cone region […] Continue reading -> Amid Global Cholera Surge, Gavi Launches New Testing Programme 10/04/2024 Zuzanna Stawiska A new programme aiming at providing 1.2 million rapid cholera diagnostic tests has been launched in 14 African and Asian countries. “Routine use of diagnostics will bolster cholera surveillance in impacted countries, and must be leveraged to better target vaccination efforts, which play a critical role in multisectoral cholera prevention and control programmes,” said Aurélia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Colombia Issues Compulsory License to Enable it to Access Generic HIV Drug, Dolutegravir 25/04/2024 Kerry Cullinan The government of Colombia has issued its first-ever compulsory license to enable access to generic versions of the key HIV medicine dolutegravir, without permission from the patent owner, ViiV Healthcare. Dolutegravir is recommended as part of the preferred first-line antiretroviral treatment regimen for people living with HIV, including during pregnancy, as per the guidance of […] Continue reading -> Immunisation Saved At Least 154 Million Lives Over Past 50 Years – WHO 24/04/2024 Kerry Cullinan Immunisation has saved at least 154 million lives over the past 50 years, since the World Health Organization (WHO) launched its Expanded Programme on Immunization (EPI) in 1974. Of the lives saved, 146 million were children under five, and 101 million were babies. Global infant deaths have reduced by 40% and more than halved in […] Continue reading -> Study Finds Adult Vaccination Programs Deliver 19x Returns 18/04/2024 Maayan Hoffman Amidst the anticipated increase in vaccine-preventable diseases as the global population ages, a first-of-its-kind study has underscored the dual benefits of adult immunization programs. Beyond saving lives and preventing severe illnesses, the study found these programs offer substantial financial advantages to nations by reducing the need for costly hospitalizations and emergency medical interventions and avoiding […] Continue reading -> Moderna’s ‘Disappointing’ Pull Back from Kenya Highlights Complexity of Expanding Vaccine Manufacturing in Africa 16/04/2024 Kerry Cullinan “Disappointed” is how the Africa Centres for Disease Control and Prevention phrased its response to pharmaceutical company Moderna “pausing” its Kenyan mRNA vaccine manufacturing facility. Moderna’s decision is yet another example of how complex it is to kickstart vaccine manufacturing on the continent – an essential component to safeguard Africans against future pandemics on the […] Continue reading -> Nigeria Becomes First Country in World to Roll out New Five-in-One Meningitis Vaccine 15/04/2024 Zuzanna Stawiska Nigeria has incorporated a cutting-edge meningitis vaccine into its immunization programmes, becoming the first country on the continent to roll it out. The vaccine provides immunity against as many as five strains of deadly meningococcus bacteria, WHO announced on Friday. “Meningitis is an old and deadly foe, but this new vaccine holds the potential to […] Continue reading -> New Dengue Vaccine Trials Show Promise in Brazil as Cases Continue to Rise 10/04/2024 Sophia Samantaroy As global cases of dengue are already close to last year’s record high of over four million, the Americas region is struggling to contain high transmission levels. Unplanned urbanization, heavier rainfall, warmer temperatures, and the El Nino effect create perfect conditions for the Aedes aegypti mosquito, the primary vector of dengue. The Southern Cone region […] Continue reading -> Amid Global Cholera Surge, Gavi Launches New Testing Programme 10/04/2024 Zuzanna Stawiska A new programme aiming at providing 1.2 million rapid cholera diagnostic tests has been launched in 14 African and Asian countries. “Routine use of diagnostics will bolster cholera surveillance in impacted countries, and must be leveraged to better target vaccination efforts, which play a critical role in multisectoral cholera prevention and control programmes,” said Aurélia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Immunisation Saved At Least 154 Million Lives Over Past 50 Years – WHO 24/04/2024 Kerry Cullinan Immunisation has saved at least 154 million lives over the past 50 years, since the World Health Organization (WHO) launched its Expanded Programme on Immunization (EPI) in 1974. Of the lives saved, 146 million were children under five, and 101 million were babies. Global infant deaths have reduced by 40% and more than halved in […] Continue reading -> Study Finds Adult Vaccination Programs Deliver 19x Returns 18/04/2024 Maayan Hoffman Amidst the anticipated increase in vaccine-preventable diseases as the global population ages, a first-of-its-kind study has underscored the dual benefits of adult immunization programs. Beyond saving lives and preventing severe illnesses, the study found these programs offer substantial financial advantages to nations by reducing the need for costly hospitalizations and emergency medical interventions and avoiding […] Continue reading -> Moderna’s ‘Disappointing’ Pull Back from Kenya Highlights Complexity of Expanding Vaccine Manufacturing in Africa 16/04/2024 Kerry Cullinan “Disappointed” is how the Africa Centres for Disease Control and Prevention phrased its response to pharmaceutical company Moderna “pausing” its Kenyan mRNA vaccine manufacturing facility. Moderna’s decision is yet another example of how complex it is to kickstart vaccine manufacturing on the continent – an essential component to safeguard Africans against future pandemics on the […] Continue reading -> Nigeria Becomes First Country in World to Roll out New Five-in-One Meningitis Vaccine 15/04/2024 Zuzanna Stawiska Nigeria has incorporated a cutting-edge meningitis vaccine into its immunization programmes, becoming the first country on the continent to roll it out. The vaccine provides immunity against as many as five strains of deadly meningococcus bacteria, WHO announced on Friday. “Meningitis is an old and deadly foe, but this new vaccine holds the potential to […] Continue reading -> New Dengue Vaccine Trials Show Promise in Brazil as Cases Continue to Rise 10/04/2024 Sophia Samantaroy As global cases of dengue are already close to last year’s record high of over four million, the Americas region is struggling to contain high transmission levels. Unplanned urbanization, heavier rainfall, warmer temperatures, and the El Nino effect create perfect conditions for the Aedes aegypti mosquito, the primary vector of dengue. The Southern Cone region […] Continue reading -> Amid Global Cholera Surge, Gavi Launches New Testing Programme 10/04/2024 Zuzanna Stawiska A new programme aiming at providing 1.2 million rapid cholera diagnostic tests has been launched in 14 African and Asian countries. “Routine use of diagnostics will bolster cholera surveillance in impacted countries, and must be leveraged to better target vaccination efforts, which play a critical role in multisectoral cholera prevention and control programmes,” said Aurélia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Study Finds Adult Vaccination Programs Deliver 19x Returns 18/04/2024 Maayan Hoffman Amidst the anticipated increase in vaccine-preventable diseases as the global population ages, a first-of-its-kind study has underscored the dual benefits of adult immunization programs. Beyond saving lives and preventing severe illnesses, the study found these programs offer substantial financial advantages to nations by reducing the need for costly hospitalizations and emergency medical interventions and avoiding […] Continue reading -> Moderna’s ‘Disappointing’ Pull Back from Kenya Highlights Complexity of Expanding Vaccine Manufacturing in Africa 16/04/2024 Kerry Cullinan “Disappointed” is how the Africa Centres for Disease Control and Prevention phrased its response to pharmaceutical company Moderna “pausing” its Kenyan mRNA vaccine manufacturing facility. Moderna’s decision is yet another example of how complex it is to kickstart vaccine manufacturing on the continent – an essential component to safeguard Africans against future pandemics on the […] Continue reading -> Nigeria Becomes First Country in World to Roll out New Five-in-One Meningitis Vaccine 15/04/2024 Zuzanna Stawiska Nigeria has incorporated a cutting-edge meningitis vaccine into its immunization programmes, becoming the first country on the continent to roll it out. The vaccine provides immunity against as many as five strains of deadly meningococcus bacteria, WHO announced on Friday. “Meningitis is an old and deadly foe, but this new vaccine holds the potential to […] Continue reading -> New Dengue Vaccine Trials Show Promise in Brazil as Cases Continue to Rise 10/04/2024 Sophia Samantaroy As global cases of dengue are already close to last year’s record high of over four million, the Americas region is struggling to contain high transmission levels. Unplanned urbanization, heavier rainfall, warmer temperatures, and the El Nino effect create perfect conditions for the Aedes aegypti mosquito, the primary vector of dengue. The Southern Cone region […] Continue reading -> Amid Global Cholera Surge, Gavi Launches New Testing Programme 10/04/2024 Zuzanna Stawiska A new programme aiming at providing 1.2 million rapid cholera diagnostic tests has been launched in 14 African and Asian countries. “Routine use of diagnostics will bolster cholera surveillance in impacted countries, and must be leveraged to better target vaccination efforts, which play a critical role in multisectoral cholera prevention and control programmes,” said Aurélia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Moderna’s ‘Disappointing’ Pull Back from Kenya Highlights Complexity of Expanding Vaccine Manufacturing in Africa 16/04/2024 Kerry Cullinan “Disappointed” is how the Africa Centres for Disease Control and Prevention phrased its response to pharmaceutical company Moderna “pausing” its Kenyan mRNA vaccine manufacturing facility. Moderna’s decision is yet another example of how complex it is to kickstart vaccine manufacturing on the continent – an essential component to safeguard Africans against future pandemics on the […] Continue reading -> Nigeria Becomes First Country in World to Roll out New Five-in-One Meningitis Vaccine 15/04/2024 Zuzanna Stawiska Nigeria has incorporated a cutting-edge meningitis vaccine into its immunization programmes, becoming the first country on the continent to roll it out. The vaccine provides immunity against as many as five strains of deadly meningococcus bacteria, WHO announced on Friday. “Meningitis is an old and deadly foe, but this new vaccine holds the potential to […] Continue reading -> New Dengue Vaccine Trials Show Promise in Brazil as Cases Continue to Rise 10/04/2024 Sophia Samantaroy As global cases of dengue are already close to last year’s record high of over four million, the Americas region is struggling to contain high transmission levels. Unplanned urbanization, heavier rainfall, warmer temperatures, and the El Nino effect create perfect conditions for the Aedes aegypti mosquito, the primary vector of dengue. The Southern Cone region […] Continue reading -> Amid Global Cholera Surge, Gavi Launches New Testing Programme 10/04/2024 Zuzanna Stawiska A new programme aiming at providing 1.2 million rapid cholera diagnostic tests has been launched in 14 African and Asian countries. “Routine use of diagnostics will bolster cholera surveillance in impacted countries, and must be leveraged to better target vaccination efforts, which play a critical role in multisectoral cholera prevention and control programmes,” said Aurélia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Nigeria Becomes First Country in World to Roll out New Five-in-One Meningitis Vaccine 15/04/2024 Zuzanna Stawiska Nigeria has incorporated a cutting-edge meningitis vaccine into its immunization programmes, becoming the first country on the continent to roll it out. The vaccine provides immunity against as many as five strains of deadly meningococcus bacteria, WHO announced on Friday. “Meningitis is an old and deadly foe, but this new vaccine holds the potential to […] Continue reading -> New Dengue Vaccine Trials Show Promise in Brazil as Cases Continue to Rise 10/04/2024 Sophia Samantaroy As global cases of dengue are already close to last year’s record high of over four million, the Americas region is struggling to contain high transmission levels. Unplanned urbanization, heavier rainfall, warmer temperatures, and the El Nino effect create perfect conditions for the Aedes aegypti mosquito, the primary vector of dengue. The Southern Cone region […] Continue reading -> Amid Global Cholera Surge, Gavi Launches New Testing Programme 10/04/2024 Zuzanna Stawiska A new programme aiming at providing 1.2 million rapid cholera diagnostic tests has been launched in 14 African and Asian countries. “Routine use of diagnostics will bolster cholera surveillance in impacted countries, and must be leveraged to better target vaccination efforts, which play a critical role in multisectoral cholera prevention and control programmes,” said Aurélia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Dengue Vaccine Trials Show Promise in Brazil as Cases Continue to Rise 10/04/2024 Sophia Samantaroy As global cases of dengue are already close to last year’s record high of over four million, the Americas region is struggling to contain high transmission levels. Unplanned urbanization, heavier rainfall, warmer temperatures, and the El Nino effect create perfect conditions for the Aedes aegypti mosquito, the primary vector of dengue. The Southern Cone region […] Continue reading -> Amid Global Cholera Surge, Gavi Launches New Testing Programme 10/04/2024 Zuzanna Stawiska A new programme aiming at providing 1.2 million rapid cholera diagnostic tests has been launched in 14 African and Asian countries. “Routine use of diagnostics will bolster cholera surveillance in impacted countries, and must be leveraged to better target vaccination efforts, which play a critical role in multisectoral cholera prevention and control programmes,” said Aurélia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Amid Global Cholera Surge, Gavi Launches New Testing Programme 10/04/2024 Zuzanna Stawiska A new programme aiming at providing 1.2 million rapid cholera diagnostic tests has been launched in 14 African and Asian countries. “Routine use of diagnostics will bolster cholera surveillance in impacted countries, and must be leveraged to better target vaccination efforts, which play a critical role in multisectoral cholera prevention and control programmes,” said Aurélia […] Continue reading -> Posts navigation Older postsNewer posts